Fol. Biol. 2021, 67, 126-133

https://doi.org/10.14712/fb2021067030126

Luteoloside Ameliorates Palmitic Acid-Induced in Vitro Model of Non-alcoholic Fatty Liver Disease via Activating STAT3-Triggered Hepatocyte Regeneration

Y. X. Zhu1, L. Zhu1, Y. F. Chen1, J. M. Xu1, Z. L. Shen1, R. J. Liu1, J. Zou1, Mingqing Yuan1, Fan Ye1, Qingqi Zeng2

1Department of Pharmacy, Affiliated Kunshan Hospital of Jiangsu University, Kunshan 215300, Jiangshu, China
2Jiangsu Health Vocational College; Nanjing 210023, China

Received May 2021
Accepted September 2021

Crossref Cited-by Linking

  • Xiu Mengxue, Zhao Yiming, Wang Xuehui, Yuan Siyu, Qin Bofeng, Sun Jinghui, Cui Long, Song Jian: Regulation of SIRT1-TLR2/TLR4 pathway in cell communication from macrophages to hepatic stellate cells contribute to alleviates hepatic fibrosis by Luteoloside. Acta Histochemica 2023, 125, 151989. <https://doi.org/10.1016/j.acthis.2022.151989>
  • Wang Lu, Yan Yonghuan, Wu Linfang, Peng Jinyong: Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development. Pharmacological Research 2023, 196, 106925. <https://doi.org/10.1016/j.phrs.2023.106925>
Crossref Cited-by Linking logo